ChinaDaily Briefs

Daily Brief China: Binjiang Service Group, Jingdong Property, Zhejiang Supcon Technology, China Overseas Land & Investment, ADICON Holdings Limited, Dongfang Electric, China Traditional Chinese Medicine, Anton Oilfield and more

In today’s briefing:

  • Binjiang 3316 HK: >30% Profit Growth, Dividend Yield~6.5%, Cash Now 37% of Market Cap
  • JD Property Pre-IPO Tearsheet
  • Zhejiang Supcon Technology GDR Listing – Momentum Has Been Strong and Not a Large Deal to Process
  • China Overseas Land & Investment Ltd (688 HK) – Large Base in 2021/2022 – Material Upside in 2023
  • ADICON Holdings IPO: Covid Driven Earnings to Decline While Growth Prospects Remain Uncertain
  • Dongfang Electric (1072 HK): Positive Takeaways from Post-Result Presentation
  • China Traditional Chinese Medicine (570.HK) – Looking Forward to a Performance Turnaround in 2023
  • Adicon Holdings Pre-IPO – Too Much Growth from COVID-19
  • Morning Views Asia: Anton Oilfield, Greentown China, Sino-Ocean Service

Binjiang 3316 HK: >30% Profit Growth, Dividend Yield~6.5%, Cash Now 37% of Market Cap

By Sameer Taneja

  • Binjiang Service Group (3316 HK) reported a solid earnings growth of 28% YoY, with revenue up 41%. Binjiang has outperformed its peers in the PMC space by a long way.
  • Net cash on the balance sheet increased to 37% of the current market capitalization, led by the growth of operating profits and payables.
  • The PE FY23e/24e now is a modest 11.2x FY23e/9.2x FY24e with dividend yield of 5.4%/6.5% FY23e/24e (assuming a 60% payout ratio).

JD Property Pre-IPO Tearsheet

By Clarence Chu

  • Jingdong Property (JDP HK) is looking to raise about US$1bn in its upcoming Hong Kong IPO.
  • JD Property (JDP) develops and manages modern infrastructure, consisting primarily of logistics parks, as well as business parks and others in China and in Asia.
  • As of Dec 22, the firm’s portfolio of Modern Infrastructure Assets has a total AUM of RMB93.7bn, occupying a total gross floor area (GFA) of 23.3m sqm. 

Zhejiang Supcon Technology GDR Listing – Momentum Has Been Strong and Not a Large Deal to Process

By Clarence Chu

  • Zhejiang Supcon Technology (688777 CH) is looking to raise around US$347m in its Swiss GDR listing. Huatai and CLSA are bookrunners on the deal.
  • The firm is offering 12.5m GDRs (1 GDR to 2 ordinary A-shares) for sale, at a 8.1-10.8% discount to last close on the A-share leg.
  • The deal is a relatively small one for the firm to digest, representing just 5.9 days of three month ADV on its A-share leg.

China Overseas Land & Investment Ltd (688 HK) – Large Base in 2021/2022 – Material Upside in 2023

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. •1) Response to key levels. •2) Price action. •3) Momentum confirmation.
  • A large triple bottom in 2021/2022 has confirmed a likely multi-year base and evolving multi-year uptrend. Q1 2023 has delivered a correction within the evolving uptrend.
  • A bullish weekly reversal pattern last week has confirmed that the 2023 correction is likely complete. Initial target at 23.20 (+11%), the break above which will target 27.35 (+30%).

ADICON Holdings IPO: Covid Driven Earnings to Decline While Growth Prospects Remain Uncertain

By Shifara Samsudeen, ACMA, CGMA

  • ADICON Holdings is one of top three independent clinical laboratories (ICL) in China based on total revenues. The company offers testing services primarily to hospitals and health check centres.
  • The company’s application for a HKEx listing has been approved and according to news media outlets, ADICON plans to raise around US$400m through the IPO.
  • Over the last three years, most of ADICON Holdings Limited (ADI HK) ’s growth were driven by Covid-19 related testing services which are likely to see huge decline going forward.

Dongfang Electric (1072 HK): Positive Takeaways from Post-Result Presentation

By Osbert Tang, CFA

  • Dongfang Electric (1072 HK)‘s management update suggested that its outlook remains encouraging. Order backlog of Rmb87.8bn well covers the FY22 revenue at 1.57x.  
  • It is positive towards pumped storage, alternative power storage and hydrogen energy. Although they may not have significant near-term contribution, DEC is well-positioned in the long term.
  • While new A-shares issue will dilute EPS, this should lower gearing (including contract liabilities) to 32.1%, from 49.2%, and is positive to H-share holders as book value will be enhanced.

China Traditional Chinese Medicine (570.HK) – Looking Forward to a Performance Turnaround in 2023

By Xinyao (Criss) Wang

  • China TCM’s concentrated TCM granules business improved significantly in 22H2, and the total revenue in 22H2 also increased by 42% YoY, indicating that the decline trend has been significantly curbed.
  • Due to its SOE background+ national standard setters with the largest number of national standards filed, China TCM would be the beneficiary of the industry’s transformation during this dividend period.
  • Due to low base last year, China TCM’s performance would rebound this year. Considering favorable policies and large growth potential in TCM granules, we’re optimistic about its share price performance.

Adicon Holdings Pre-IPO – Too Much Growth from COVID-19

By Ethan Aw

  • ADICON Holdings Limited (ADI HK) is looking to raise about US$400m in its upcoming HK IPO. 
  • Adicon Holdings is one of the top three independent clinical laboratory (ICL) service providers in China in terms of total revenue during the Track Record Period, according to F&S. 
  • Adicon’s revenue growth has been driven by its medical diagnostic testing services segment, during the track record period. However, much of its growth appears to be driven by COVID-19 testing. 

Morning Views Asia: Anton Oilfield, Greentown China, Sino-Ocean Service

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars